ClinicalTrials.gg
RecruitingNCT06727708BiocircuitUpdated Dec 11, 2024

Comparison of Two BioCircuit Programs: Impact on Physical Fitness and Body Composition in Adults Aged 30-65

An interventional study of Tone Your Body BioCircuit Program and Boost Performance BioCircuit Program in Muscle Strength, Body Composition and Physical Fitness, sponsored by University of Graz. Recruiting at 1 site in Austria. Open to participants aged 30 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-11.

Sponsored by University of Graz · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year ago, but the record still lists the study as recruiting.
  • Started Oct 2024; still recruiting 2 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
30 Years to 65 Years
Sex
All
01

Study summary

This study aims to compare the effects of two BioCircuit training programmes, 'Tone Your Body' and 'Boost Performance', on physical fitness and body composition in adults aged 30-65 years. Participants will be randomized to one of the two exercise programmes and will undergo a 12-week intervention with baseline and post-intervention measurements of fitness and body composition. The study aims to determine which programme is more effective in improving overall physical fitness, muscle mass and reducing body fat.

Read the detailed description

The aim of this study is to compare the effects of two BioCircuit training programmes, 'Tone Your Body' and 'Boost Performance', on physical fitness and body composition in adults aged 30-65 years. The aim is to determine whether these programmes achieve their intended outcomes - specifically, whether Tone Your Body is effective in reducing body fat while promoting muscle toning, and whether Boost Performance improves strength and endurance. The study will assess which of the two programmes leads to greater improvements in muscle mass, body fat reduction and overall physical fitness.

The study is designed as a randomised parallel group trial using a minimisation technique to ensure that key variables such as age, gender and baseline handgrip strength are balanced between the two groups. Participants will be assigned to one of two BioCircuit programmes: "Tone Your Body" or "Boost Performance". Each programme consists of six total body strength exercises and two cardio exercises, both structured in a circuit format. Each exercise is performed for 45 seconds, followed by a 40-second rest between machines. The endurance exercises are performed for 3 minutes and 35 seconds each. The intervention will last 12 weeks, with participants training three times a week on Technogym's BioCircuit equipment, which provides personalised, automated training based on individual fitness levels.

The Tone Your Body group focuses on improving body composition through moderate-intensity whole-body resistance exercise combined with cardio training. This programme is designed to reduce body fat while promoting muscle toning, with an emphasis on overloading the eccentric phase of each repetition by 20% to maximise muscle development.

The Boost Performance group aims to improve physical performance, particularly strength and endurance. This programme involves higher intensity resistance training with a viscous resistance mechanism designed to build muscle strength, power and endurance. Participants in this group will also undergo performance tests, including the jump and reach test, one-minute squats and one-minute push-ups, to assess improvements in explosive strength and muscular endurance.

Both groups will undergo the same 10RM strength tests at baseline and post-intervention using the Smith machine for bench press and leg press to measure maximum strength. In addition, all participants, regardless of group, will undergo the same assessments at baseline and post-intervention, including measurements of body composition (using bioimpedance analysis), muscle mass, body fat percentage, and physical performance tests. Circumference measurements of the arms, legs and waist will also be taken to track changes in body composition over time. Participants will be instructed to maintain their usual dietary habits throughout the 12-week intervention period. They will be asked not to make any significant changes to their diet or to introduce any new dietary supplements, as these could influence the outcomes related to muscle strength, body composition and overall physical fitness.

The primary outcome measures will focus on changes in skeletal muscle mass, body fat percentage and overall physical fitness. Secondary outcomes will include participant satisfaction with the programme as measured by a standardised customer satisfaction questionnaire (CSAT) and changes in circumference measurements.

Participants will be healthy adults aged 30-65 years with less than six months experience of resistance training. Individuals with a history of coronary heart disease, stroke or conditions that would affect their ability to participate in exercise will be excluded from the study. Recruitment will take place through a local fitness centre and all participants will provide written informed consent before the start of the study.

This study aims to provide valuable insights into the effectiveness of BioCircuit training programmes in a real-world setting. The results will help inform future fitness interventions and provide evidence for the benefits of automated, personalised training programmes in improving body composition and physical performance in adults.

02

Conditions studied

  • Muscle Strength
  • Body Composition
  • Physical Fitness

Keywords

  • Circle Training
  • Strength training
  • Muscle mass
  • Body composition
  • Physical fitness
  • BioCircuit
  • Resistance training
  • Body fat reduction
  • Randomized controlled trial
  • Handgripstrength
03

In context

Lead sponsor

University of Graz is the lead sponsor of 6 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Age between 30 and 65 years

      • Healthy individuals without significant medical conditions
      • Less than 6 months of prior strength training experience
      • Willing and able to participate in a 12-week training program
      • Capable of performing strength training exercises such as leg press and chest press
      • Able to provide written

Exclusion criteria

Exclusion Criteria:

    • History of coronary heart disease

      • History of stroke
      • Need for changes in antihypertensive treatment within 3 months prior to study start
      • Arthritis
      • Pregnancy or less than three months postpartum
      • Pain and movement restrictions
      • Use of medications that affect muscle strength or performance (e.g., anabolic steroids, beta-2 agonists, , statins, benzodiazepines, ACE inhibitors, angiotensin-II receptor blockers, diuretics)
      • Any medical condition preventing participation in planned endurance and strength training
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
42 participants (estimated)

Study arms

  • Experimental
    Tone Your Body Group

    Participants in the Tone Your Body group follow a 12-week BioCircuit training programme designed to improve body composition and muscle toning. The programme consists of six total-body strength exercises and two cardio exercises in a circuit format. Each exercise is performed for 45 seconds, followed by a 40-second rest between machines. The endurance exercises are performed for 3 minutes and 35 seconds each. The eccentric phase of each strength exercise is overloaded by 20% to maximise muscle development.

    Device: Tone Your Body BioCircuit Program

  • Experimental
    Boost Performance Group

    Participants in the Boost Performance group follow a 12-week BioCircuit training programme designed to increase strength and endurance. The programme consists of six strength exercises and two cardio exercises, also in a circuit format. Each exercise is performed for 45 seconds, with 40 seconds rest between machines, and the endurance exercises are performed for 3 minutes and 35 seconds. The strength exercises use a viscous resistance mechanism to increase strength and endurance. Participants also undergo performance tests including the jump and reach test, one minute squats and one minute push-ups.

    Device: Boost Performance BioCircuit Program

Interventions

  • DeviceTone Your Body BioCircuit Program

    Participants in the Tone Your Body group follow a 12-week BioCircuit training programme designed to improve body composition and muscle toning. The programme consists of six total-body strength exercises and two cardio exercises in a circuit format. Each exercise is performed for 45 seconds, followed by a 40-second rest between machines. The endurance exercises are performed for 3 minutes and 35 seconds each. The eccentric phase of each strength exercise is overloaded by 20% to maximise muscle development.

  • DeviceBoost Performance BioCircuit Program

    Participants in the Boost Performance group follow a 12-week BioCircuit training programme designed to increase strength and endurance. The programme consists of six strength exercises and two cardio exercises, also in a circuit format. Each exercise is performed for 45 seconds, with 40 seconds rest between machines, and the endurance exercises are performed for 3 minutes and 35 seconds. The strength exercises use a viscous resistance mechanism to increase strength and endurance. Participants also undergo performance tests including the jump and reach test, one minute squats and one minute push-ups.

06

What researchers measure

Primary outcomes

  1. Change in Skeletal Muscle Mass

    Skeletal muscle mass will be measured using bioimpedance analysis (BIA) at baseline and after the 12-week intervention to evaluate changes in muscle mass.

    Time frame: Baseline and Week 12

  2. Change in Body Fat Percentage

    Body fat percentage will be measured using bioimpedance analysis (BIA) at baseline and after the 12-week intervention to assess reductions in body fat.

    Time frame: Baseline and Week 12

  3. Change in Maximal Strength (10-RM Test)

    Maximal strength will be measured using the 10-RM test on the Smith machine for bench press and leg press at baseline and after the 12-week intervention.

    Time frame: Baseline and Week 12

  4. Change in Handgrip Strength

    Handgrip strength will be measured using a dynamometer at baseline and after the 12-week intervention.

    Time frame: Baseline and Week 12

Secondary outcomes

  1. Change in Circumference Measurements (Arm, Leg, and Waist)

    Circumference measurements of the arms, legs, and waist will be taken at baseline and after the 12-week intervention to track changes in body composition.

    Time frame: Baseline and Week 12

  2. Customer Satisfaction (CSAT Questionnaire)

    Participant satisfaction with the training program will be assessed using the CSAT questionnaire at the end of the 12-week intervention.

    Time frame: Week 2 and Week 12

  3. Change in Jump and Reach Performance

    Performance will be evaluated by measuring the vertical jump height using the jump and reach test at baseline and after the 12-week intervention.

    Time frame: Baseline and Week 12

  4. Change in Squat Performance (One-Minute Squat Test)

    Performance will be evaluated by counting the number of squats completed in one minute at baseline and after the 12-week intervention.

    Time frame: Baseline and Week 12

  5. Change in Push-up Performance (One-Minute Push-up Test)

    Performance will be evaluated by counting the number of push-ups completed in one minute at baseline and after the 12-week intervention.

    Time frame: Baseline and Week 12

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The individual participant data (IPD) used in the published results will be shared in an anonymized format. Access will be provided upon request through a secure data repository for researchers who meet the criteria for access to confidential data.

Supporting information: Study protocol

Time frame: Available upon publication for one year.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2024 (actual). Primary completion is estimated for Oct 2025, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 30, 2024
First posted
Dec 11, 2024
StartActual
Oct 31, 2024
Primary completionEst.
Oct 31, 2025
CompletionEst.
Oct 31, 2025
Last update
Dec 11, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06727708
Lead sponsor
University of Graz
Responsible party
Sponsor
First posted
Dec 11, 2024
Start date
Oct 31, 2024
Primary completion
Oct 31, 2025 (estimated)
Completion
Oct 31, 2025 (estimated)
Last update
Dec 11, 2024

Study contacts

Martin Atia
Contact
atia.martin@hotmail.com
+436642524153
Martin Atia
principal investigator · University of Graz

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion